Jasper Therapeutics, Inc.
JSPR
$0.46
$0.00-0.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 20.28M | 21.30M | 22.47M | 21.29M | 20.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.58M | 91.52M | 94.05M | 82.97M | 76.24M |
| Operating Income | -81.58M | -91.52M | -94.05M | -82.97M | -76.24M |
| Income Before Tax | -75.80M | -91.02M | -90.92M | -78.78M | -71.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -75.80 | -91.02 | -90.92 | -78.78 | -71.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -75.80M | -91.02M | -90.92M | -78.78M | -71.27M |
| EBIT | -81.58M | -91.52M | -94.05M | -82.97M | -76.24M |
| EBITDA | -80.53M | -90.51M | -92.73M | -81.61M | -74.87M |
| EPS Basic | -4.60 | -5.90 | -6.02 | -5.25 | -4.87 |
| Normalized Basic EPS | -2.80 | -3.62 | -3.76 | -3.28 | -3.04 |
| EPS Diluted | -4.60 | -5.90 | -6.02 | -5.25 | -4.87 |
| Normalized Diluted EPS | -2.80 | -3.62 | -3.76 | -3.28 | -3.04 |
| Average Basic Shares Outstanding | 75.66M | 62.00M | 60.37M | 60.02M | 58.33M |
| Average Diluted Shares Outstanding | 75.66M | 62.00M | 60.37M | 60.02M | 58.33M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |